Health TrialsbyHealthPanel

Effect of Ajwa Seed Powder on HbA1c and Body Composition in Overweight and Obese Patients With Type 2 Diabetes Mellitus

ConditionsObesity & OverweightType 2 Diabetes (T2DM)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-50
SponsorUniversity of Veterinary and Animal Sciences, Lahore - Pakistan

About this trial

The goal of this interventional study (clinical trial) is to check if ajwa seed powder can treat type 2 diabetes mellitus in overweight and and obese patients with type 2 diabetes mellitus including both male and female of the age group between 30-50. The main question is what would be the impact of ajwa seed powder on HbA1c and body composition in overweight and obese patients with type 2 diabetes mellitus which aim to

result in better glycemic control particular Hba1c, and body composition improvement in type 2 diabetes mellitus patients

Participants will be asked to consume 4 grams of ajwa seed powder per day

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: 30-50 years

Gender: Male/female

Body Mass Index (BMI): 25-35 kg/m²

Type 2 diabetes mellitus: HbA1c ≥ 6.5%

Disqualifiers

Patients being treated with insulin

High initial levels of serum creatinine (men>1.5 mg/dl; women>1.2 mg/dl)

Pregnant/lactating females or women who cannot take proper contraceptive measures

Symptoms consistent with peptic ulcer disease or history of peptic ulcers

Trial design

Design model

Single group

Treatments tested in this trial

  • Ajwa Seed powder

    Dietary supplement

    The intervention in this study is Ajwa (Phoenix dactylifera) seed powder, a natural plant-based product obtained from Ajwa dates. It is distinguished from other clinical interventions by its botanical origin, absence of chemical modification, and standardized preparation process, which includes cleaning, drying, and grinding into a uniform powder form. A fixed dose is administered to all participants in the intervention arm according to the study protocol. Unlike pharmaceutical or biologic interventions, it is a non-pharmacological dietary supplement intended for metabolic support. The intervention specifically targets HbA1c levels and body composition in diabetic and/or obese individuals, with no additional experimental treatments included. This controlled and standardized approach differentiates it from other clinical or nutritional interventions.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Ajwa Seed powder groupOther 1 intervention

Trial outcomes

Primary outcomes

1

change in HbA1c concentration (%) from baseline to week 12 in 30 overweight and obese patients with type 2 diabetes mellitus

Time frame
12 weeks

Secondary outcomes

1

Weight in kg

Time frame
12 weeks
2

Height in meter

Time frame
12 weeks
3

Waist circumference in cm

Time frame
12 weeks
4

Hip circumference in cm

Time frame
12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Veterinary and Animal Sciences, Lahore - Pakistan

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: